Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing, our testing is designed to detect and monitor therapeutic and illicit drugs across several relevant specimen types.
Join us for the APA Annual Meeting 2023, the premier event for psychiatrists and mental health professionals. This year's meeting will be held May 20–24 in San Francisco and will feature an exciting program of educational sessions, expert speakers, and networking opportunities.
A medical mystery surrounding a clotting disease spurred a collaboration between Mayo Clinic and University of Michigan Health to develop a new test methodology and the discovery of a previously unknown blood clotting condition.
A specific type of fungal species, Candida auris, is raising concern in health care facilities around the world. First discovered in Japan in 2009, Candida auris is responsible for an increasing number of serious and often fatal fungal infections. Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic Laboratories, explains why these infections are difficult to treat.
Discover the latest advancements in parasitology at the 2023 Parasitology Workshop presented by Mayo Clinic Laboratories. This two-day interactive workshop held Aug. 11-12 will provide hands-on laboratory experience, presentations by subject matter experts, review of laboratory identification methods, and an algorithmic approach to parasite identification, including conventional and molecular techniques.
Thank you to all laboratory professionals for their efforts to provide critical answers for patients every day, and drive innovation in the field of medicine.
Top highlights include: Millions expected to lose dental care coverage, overdose deaths of elderly on the rise, and Minnesota Health Department urges caution for well owners as flood waters rise.
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides an update on the ongoing global avian influenza outbreak and what’s being done to prepare for a potential human-to-human outbreak.
Top highlights include: Adderall shortage is taking a toll, scientists are reconsidering the dangers of prospecting for unknown viruses, and can community paramedcine improve health outcomes in rural America?
Mayo Clinic Laboratories is excited to participate in the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023.
Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.
Mayo Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023.